Financial reports
NT 10-K
Notice of late annual filing
14 Jun 11
10-Q
2011 Q3
Quarterly report
9 Feb 11
10-Q
2011 Q2
Quarterly report
8 Nov 10
ARS
2010 FY
Annual report to shareholders
13 Aug 10
10-Q
2011 Q1
Quarterly report
5 Aug 10
10-K
2010 FY
Annual report
9 Jun 10
10-Q
2010 Q3
Quarterly report
12 Feb 10
10-Q
2010 Q2
Quarterly report
9 Nov 09
10-Q
2010 Q1
Quarterly report
10 Aug 09
ARS
2009 FY
Annual report to shareholders
30 Jul 09
Current reports
8-K
Caraco Announces Stockholder Approval of Merger Agreement
14 Jun 11
8-K
Caraco Announces Merger Agreement with Sun Pharma; Caraco Public Shareholders to Receive $5.25 Cash per Share
22 Feb 11
8-K
Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2011
31 Jan 11
8-K
Caraco Pharmaceutical Laboratories, Ltd. Announces Extension and Future Termination of Distribution Agreements with Sun Pharma
27 Dec 10
8-K
Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2011
29 Oct 10
8-K
Departure of Directors or Certain Officers
8 Oct 10
8-K
Caraco Pharmaceutical Laboratories, Ltd. Announces Appointment of Eddie Munson to Board of Directors
15 Sep 10
8-K
Unregistered Sales of Equity Securities
30 Aug 10
8-K
Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2011
28 Jul 10
8-K
Caraco Pharmaceutical Laboratories, Ltd. Receives Notice Regarding NYSE Amex Continued Listing Standards
15 Jul 10
Registration and prospectus
15-12B
Securities registration termination
27 Jun 11
25-NSE
Exchange delisting
17 Jun 11
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Jun 11
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Jun 11
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Jun 11
SC 13E3/A
Going private transaction (amended)
14 Jun 11
SC 13E3/A
Going private transaction (amended)
10 May 11
SC 13E3/A
Going private transaction (amended)
6 May 11
SC 13E3/A
Going private transaction (amended)
18 Apr 11
SC 13E3
Going private transaction
16 Mar 11
Proxies
DEFM14A
Proxy related to merger
10 May 11
PRER14A
Preliminary revised proxy
6 May 11
PRER14A
Preliminary revised proxy
18 Apr 11
PREM14A
Preliminary proxy related to merger
16 Mar 11
DEF 14A
Definitive proxy
29 Jul 10
DEF 14A
Definitive proxy
6 Oct 09
PRE 14A
Preliminary proxy
23 Sep 09
DEFR14A
Revised proxy
3 Aug 09
DEF 14A
Definitive proxy
29 Jul 09
DEF 14A
Definitive proxy
29 Jul 08
Other
CT ORDER
Confidential treatment order
5 Apr 12
CORRESP
Correspondence with SEC
6 May 11
CT ORDER
Confidential treatment order
6 May 11
UPLOAD
Letter from SEC
22 Apr 11
CORRESP
Correspondence with SEC
18 Apr 11
UPLOAD
Letter from SEC
8 Apr 11
CT ORDER
Confidential treatment order
11 Feb 11
UPLOAD
Letter from SEC
25 May 10
CORRESP
Correspondence with SEC
12 May 10
CORRESP
Correspondence with SEC
6 May 10